date,title,source
Oct-17-18,Billionaire Tech Titans Award Millions to Make Scientists Stars,Bloomberg
Oct-17-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Gogo, Jagged Peak Energy, Everbridge, Roku, Corium International, and Ionis Pharmaceuticals  New Research Emphasizes Economic Growth",GlobeNewswire
Oct-22-18,Phase 1b/2 Data of Durvalumab Plus Danvatirsen Presented at European Society for Medical Oncology,PR Newswire
Oct-23-18,Dr. C. Frank Bennett Receives Leslie Gehry Brenner Prize for Innovation in Science,PR Newswire
Oct-24-18,Today's Research Reports on Trending Tickers: Sage Therapeutics and Ionis Pharmaceuticals,ACCESSWIRE
Oct-24-18,Ionis Pharmaceuticals to Hold Third Quarter 2018 Financial Results Webcast,PR Newswire
Oct-31-18,Advances in Ionis' Novel Antisense Technology to be Presented at 2018 Society for Neuroscience Meeting,PR Newswire
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-06-18,"Ionis Pharmaceuticals (IONS) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-06-18,Ionis Pharmaceuticals: 3Q Earnings Snapshot,Associated Press
Nov-06-18,Ionis Reports Third Quarter 2018 Financial Results,PR Newswire
Nov-07-18,Edited Transcript of IONS earnings conference call or presentation 6-Nov-18 4:30pm GMT,Thomson Reuters StreetEvents
Nov-07-18,Ionis Pharmaceuticals to Present at Upcoming Investor Conferences,PR Newswire
Nov-08-18,"Recent Analysis Shows Automatic Data Processing, GTx, Ionis Pharmaceuticals, TriNet Group, Ternium S.A, and UNIVERSAL INSURANCE HOLDINGS INC Market Influences  Renewed Outlook, Key Drivers of Growth",GlobeNewswire
Nov-08-18,Akcea and Ionis Announce Late-Breaking Presentation of Data From AKCEA-APO(a)-LRx at the American Heart Association Scientific Sessions,GlobeNewswire
Nov-09-18,Ionis Pharmaceuticals to Host Investor Day,PR Newswire
Nov-12-18,5 Pharma Stocks to Stay Away From,InvestorPlace
Nov-12-18,Ionis Pharmaceuticals Collects Royalties -- and Spends It All,Motley Fool
Nov-12-18,Phase 2 Results on AKCEA-APO(a)-LRx Presented in Late-Breaking Clinical Trial Presentation at AHA Scientific Sessions,GlobeNewswire
Nov-13-18,Ionis Pharmaceuticals to Present at Jefferies 2018 London Healthcare Conference,PR Newswire
Nov-14-18,Stocks Not in a Bouncy Mood Yet,Zacks
Nov-19-18,Edited Transcript of IONS earnings conference call or presentation 6-Nov-18 4:30pm GMT,Thomson Reuters StreetEvents
Nov-27-18,First-in-class therapies using advanced antisense chemistries highlighted at 2018 American Society of Hematology Annual Meeting,PR Newswire
Nov-29-18,Why Pfizer Could Lead These Two Biotech Stocks In Tackling Amyloidosis,Investor's Business Daily
Dec-06-18,Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data,GlobeNewswire
Dec-11-18,"Is Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Expensive For A Reason? A Look At The Intrinsic Value",Simply Wall St.
Dec-12-18,"Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate",Zacks
Dec-13-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis",Zacks
Dec-14-18,"Should You Buy Ionis Pharmaceuticals, Inc. (IONS)?",Insider Monkey
Dec-20-18,Ionis Pharmaceuticals outlines CEO succession plan,MarketWatch
Dec-20-18,Ionis Announces Plans for Management Transitions in 2020,PR Newswire
Dec-20-18,"New Research: Key Drivers of Growth for Baxter International, Sempra Energy, Nielsen Holdings Plc, ARRIS International plc, Ionis Pharmaceuticals, and KB Home  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Dec-21-18,Why Gene Therapy Is More Cost Effective Than Biogen's Approved Drug,Investor's Business Daily
Dec-31-18,4 of the Fastest Growing Biotech Stocks in 2019,Motley Fool
Jan-02-19,"Cannabis, Migraines, Gene-Silencing: FDA Approvals Hit High Note In 2018",Investor's Business Daily
Jan-02-19,Ionis Pharmaceuticals to Present at 37th Annual J.P. Morgan Healthcare Conference,PR Newswire
Jan-02-19,Top Picks 2019- Ionis Pharmaceuticals IONS,MoneyShow
Jan-14-19,This Biotech Stock Plunged On Its Looming Rivalry With Pfizer,Investor's Business Daily
Jan-15-19,Pfizer Gets FDA's Priority Review for Rare Disease Candidate,Zacks
Jan-16-19,4 Defensive Stocks to Buy Amid Shutdown and Brexit,Zacks
Jan-24-19,Is This 'Perennial' Innovator Making A Comeback Among Biotech Stocks?,Investor's Business Daily
Jan-24-19,Ironwood Commences Phase I Study on IW-6463 for CNS Disorders,Zacks
Jan-28-19,Has Ionis Pharmaceuticals (IONS) Outpaced Other Medical Stocks This Year?,Zacks
Jan-28-19,First Patient Enrolled in Pivotal Study of RG6042 (IONIS-HTT Rx) for People with Huntington's Disease,PR Newswire
Jan-30-19,Biogen Looks to 2020,Motley Fool
Jan-30-19,Ionis Wins Price Target Hike On Partner Biogen's Guidance,Benzinga
Feb-12-19,"Is Ionis Pharmaceuticals, Inc.s (NASDAQ:IONS) CEO Pay Fair?",Simply Wall St.
Feb-13-19,Ionis Pharmaceuticals to Hold 2018 Financial Results Webcast,PR Newswire
Feb-14-19,Is Moderna a Buy?,Motley Fool
Feb-20-19,Analysts Estimate Ionis Pharmaceuticals (IONS) to Report a Decline in Earnings: What to Look Out for,Zacks
Feb-25-19,Novartis aims to pump up cardio business with Ionis deal,Reuters
Feb-25-19,Novartis In-Licenses Rights to Heart Candidate From Ionis,Zacks
Feb-27-19,Ionis Pharmaceuticals (IONS) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-27-19,Here's Why Ionis Pharmaceuticals Jumped Higher Today,Motley Fool
Feb-27-19,Ionis Exceeds 2018 Financial Guidance,PR Newswire
Feb-28-19,Edited Transcript of IONS earnings conference call or presentation 27-Feb-19 4:30pm GMT,Thomson Reuters StreetEvents
Mar-01-19,"Ionis Pharmaceuticals Inc (IONS) Files 10-K for the Fiscal Year Ended on December 31, 2018",GuruFocus.com
Mar-01-19,EU committee approves Akcea-Ionis drug for rare genetic disease,Reuters
Mar-01-19,Akcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen),GlobeNewswire
Mar-04-19,Edited Transcript of IONS earnings conference call or presentation 27-Feb-19 4:30pm GMT,Thomson Reuters StreetEvents
Mar-04-19,Ionis Pharmaceuticals Funds Its Pipeline of More Than 40 Drugs,Motley Fool
Mar-04-19,"Detailed Research: Economic Perspectives on Huntsman, eHealth, Ionis Pharmaceuticals, Arch Capital Group, Copart, and Acorda Therapeutics  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Mar-05-19,Edited Transcript of IONS earnings conference call or presentation 27-Feb-19 4:30pm GMT,Thomson Reuters StreetEvents
Mar-07-19,Ionis Pharmaceuticals to Present at Upcoming Investor Conferences,PR Newswire
Mar-08-19,IBD Stock Of The Day Obliterates Earnings Views And Eyes New Buy Point,Investor's Business Daily
Mar-08-19,6 of the Most Expensive Stocks That Could Go On Sale,InvestorPlace
Mar-15-19,Akcea and Ionis Announce Upcoming Data Presentations at the 2019 American College of Cardiology Meeting (ACC.19),GlobeNewswire
Mar-25-19,Ionis announces appointment of Brett P. Monia Ph.D. to its board of directors,PR Newswire
Mar-27-19,S&P Fights Past Growth Concerns to Reclaim 2800,Zacks
Apr-04-19,7 A-Rated Healthcare Stocks for Industry Expansion,InvestorPlace
Apr-04-19,1 Biotech That Biogen Should Buy ... but Probably Won't,Motley Fool
Apr-04-19,Achillion Meets Enrollment Target in Kidney Disease Studies,Zacks
